Form 4: Merck & Co. Director, Mary Ellen Coe, Reports Acquisition of Phantom Stock Units

Mary Ellen Coe, a director at Merck & Co., reported the acquisition of phantom stock units settled in cash, according to a recent SEC Form 4 filing.

Summary

• On June 28, 2024, Mary Ellen Coe, a director of Merck & Co., reported a transaction involving phantom stock.
• Coe acquired 242.3263 units of phantom stock at a price of $123.8 per unit.
• These phantom stock units will be settled 100% in cash upon Coe's termination of service, following a distribution schedule elected under the Plan for Deferred Payment of Directors' Compensation.
• Following the reported transaction, Coe directly owns 23,169.6876 shares of Merck & Co. common stock, which includes shares acquired through dividend reinvestment transactions.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing a stock transaction. It doesn't inherently convey positive or negative sentiment.

Future Outlook

The phantom stock units will be settled in cash upon the director's termination of service, according to a pre-determined distribution schedule.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to investors regarding the actions of company leadership.

Key Dates